《復牌表現》平安證券(00231.HK)擬向首席執行官配股 股價飆升1.1倍重越牛熊線
平安證券集團(00231.HK)擬向首席執行官配股,該股今天復牌重越牛熊線(3.4仙),最高見4.4仙,創逾四個月高,現造4仙,飆升1.1倍,成交激增至1.3億股,為近年半最多,涉資491萬元。
平安證券公布,與首席執行官張錦輝訂立不具法律約束力諒解備忘錄,張氏已同意認購公司股份,所得款項將用於結算有關集團清算和重組專業費,以及結算集團的未償還債務。目前,張氏持有公司股本2.85%及本金總額2,500萬元可換股債券。認購完成後,張氏應向公司提供本金額最多2億元貸款融資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.